secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001641489-25-000038
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics stockholders elect seven directors and ratify Ernst & Young as auditor for 2025
--------------------------------------------------------------------------------

- All seven director nominees elected: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne Phillips, Paul Sekhri, Daniel K. Spiegelman.
- Votes for director nominees ranged from 2.07M to 2.18M shares; broker non-votes of 219,013 on each.
- Ratification of Ernst & Young as independent auditor: 2,400,291 For, 3,852 Against, 1,416 Abstain, 0 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/0001641489-25-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/vtvt-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001641489-25-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer